![]() |
|
W. L. Lau (1), M. H. Festing (2), C. M. Giachelli (2)
(1) Nephrology, University of Washington, Seattle, Washington, USA; (2) Bioengineering, University of Washington, Seattle, Washington, USA
Elevated serum phosphate is a risk factor for vascular calcification and cardiovascular events in kidney disease as well as in the general population. Elevated phosphate levels drive vascular calcification, in part, by regulating vascular smooth muscle cell (VSMC) gene expression, function, and fate. The type III sodium-dependent phosphate co-transporter, PiT-1, is necessary for phosphate-induced VSMC osteochondrogenic phenotype change and calcification, and has recently been shown to have unexpected functions in cell proliferation and embryonic development.
phosphate, vascular calcification, PiT-1, kidney disease
| 1. | ||
Clemens Grupp, Florian Weber arthritis + rheuma 2006 26 1: 22-26 | ||
| 2. | ||
Lorenz C. Hofbauer 1 , Jörg Schrader1 , Ute Niebergall1 , Volker Viereck2 , Andreas Burchert 1 , Dieter Hörsch1 , Klaus T. Preissner3 , Michael Schoppet1 Thrombosis and Haemostasis 2006 95 4: 708-714 http://dx.doi.org/10.1160/TH05-12-0800 | ||
| 3. | ||
See also Editorial by Flaker, Kumar S. Manzano-Fernandez (1), F. Cambronero (1), C. Caro-Martínez (1), J. A. Hurtado-Martínez (1), F. Marín (1), F. J. Pastor-Pérez (1), A. Mateo-Martínez (1), M. Sánchez-Martínez (1), E. Pinar-Bermudez (1), M. Valdés (1) Thrombosis and Haemostasis 2012 107 1: 51-58 http://dx.doi.org/10.1160/TH11-08-0524 | ||